Jon McGarity
President & CEO
INSYS Therapeautics, Inc.
Jon W. McGarity has served since March 2007 as the President & CEO and a member of the Board of Directors of INSYS Therapeutics, Inc., a privately held biopharmaceutical company with a focus on chemotherapy induced nausea and vomiting, pain management and CNS disorders. From February 1966 until March 2007, he was the President & CEO of EthiX Associates, his own consultancy business serving the pharmaceutical and biotechnology industries. In addition he also served as the President & CEO of the Arizona BioIndustry Association from August 2004 until March 2007. Currently Mr. McGarity sits on the Boards of the Arizona BioIndustry Association, Arizona Technology Council, Arizona Bioscience Roadmap Steering Committee, Global Advisory Council at Thunderbird School of Global Management, Northern Arizona Technology and Business Incubator, Leadership Council for Arizona Biomedical Research, Arizona State University Technopolis and Entrepreneur Mentoring Programs and the Masters Level Computational Biosciences Degree Program at Arizona State University.
Currently he is a Board Director at Cypress Biosciences Inc. (CYPB), a public biotech company based in San Diego as well as INSYS Therapeutics, Inc., GenBioPro, Inc., Restorative Biosciences, Inc. (formerly Cynexus Corporation) and Apthera, Inc. (formerly Advanced Peptide Therapeutics, Inc.), private biotechnology companies based in Phoenix. He is also a Board Director for Clinical Information Network, Inc. which is focused on video promotion to improve pharmaceutical sales force productivity. Mr. McGarity co-founded and was Vice Chairman, President & COO of Pharmaceutical Marketing Services, Inc., a publicly traded technology, data services and consulting business to the international pharmaceutical industry. He has functioned in his consulting business as the acting CEO of three biotechnology start ups as well as President & COO of a preclinical drug development business. His pharmaceutical experience includes senior management positions with GlaxoSmithKline, Bristol Myers Squibb and Novartis (Sandoz Pharmaceuticals). Mr. McGarity has launched over 40 products as well as completing numerous business development deals involving product acquisitions, licensing, co-marketing and promotional arrangements.
Mr. McGarity earned a BS (Pre-med) at the State University of New York in Albany, and has accomplished numerous executive courses at Harvard, Duke, Stanford, Wharton, Columbia, UCLA, and the University of Michigan.